TCL Archive No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis September 26, 1975
TCL Archive FDA Oncology Division Director Says Goal to Make Review Process “Predictable” August 2, 1996
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive In Brief: Upton Not Planning To Leave NCI, As Hinted By Califano, Over New Ethics Regulations March 30, 1979